# Fenwal International, Inc. – FDA Inspection, Apr 25, 2023

Source: https://www.keypedia.com/records/fda_inspections/fenwal-international-inc/7d702843-f19a-4cf0-9526-506bace84e14
Source feed: FDA_Inspections

> FDA inspection 1203534 of Fenwal International, Inc., April 25, 2023. Classification: Voluntary Action Indicated (VAI). 14 citations under 21 CFR part 820. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1203534
- Company Name: Fenwal International, Inc.
- Inspection Date: 2023-04-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 14

## Related Documents

- FDA Inspection 1116846 - 2019-11-15
- FDA Inspection 987674 - 2016-09-29

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/creighton-t-tuzon/be0d09c0-59f4-48c3-9e3d-a1ceb2587e3e)
- [FDA Associated Person](https://www.keypedia.com/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da)

Company: https://www.keypedia.com/companies/fenwal-international-inc/79f82b01-30b1-470b-8e6a-2d07c4452b48

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
